Zai Lab Files To Raise $150 Million For Venture Fund

Shanghai's Zai Lab filed in the US to begin raising $150 million for its own venture fund. The company isn't talking about the fund yet, but its CEO, Samantha Du, PhD, is listed as the General Partner. Dr. Du has a high profile in China, having served as CEO of Hutchison MediPharma, partner at Sequoia Capital China, and since 2014, as Founder, Chairman and CEO of Zai Lab. In three years, Zai has in-licensed seven drug candidates from six companies. The official name of the fund is Zai Venture Fund I, suggesting venture capital could be an ongoing Zai activity.